Ocrelizumab B-cell repopulation-guided extended interval dosing versus standard dosing – similar clinical efficacy with decreased immunoglobulin M deficiency rates
Multiple Sclerosis and Related Disorders2023cited by 25position: middledoi
Anti-MOG associated disorder–Clinical and radiological characteristics compared to AQP4-IgG+ NMOSD–A single-center experience
Multiple Sclerosis and Related Disorders2020cited by 49position: middledoi